SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-07-043499
Filing Date
2007-05-29
Accepted
2007-05-29 15:15:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-C a07-15397_18k.htm SC TO-C 33304
2 EX-2.1 a07-15397_1ex2d1.htm EX-2.1 683734
3 EX-99.1 a07-15397_1ex99d1.htm EX-99.1 34753
4 GRAPHIC g153971nai001.jpg GRAPHIC 2133
5 GRAPHIC g153971nai002.jpg GRAPHIC 2490
  Complete submission text file 0001104659-07-043499.txt   760491
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Subject) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC TO-C | Act: 34 | File No.: 005-78274 | Film No.: 07883508
SIC: 2834 Pharmaceutical Preparations